The Made in Italy Official Portal in the USAItaltrade.com
About Us Contact Site Map Links

The Made in Italy Business Directory

Your Business Proposals
Italian Companies
News
Business Events
Focus On
Showroom
Spotlight
International Press Room
Fairs in Italy
Coming Up
Training & Seminars
Machines Italia
Annual Report
Italy in the world
market





Italian Scientists and Scholars of North America Foundation




Home > USA > Meet Italy at Bio 2007


BIONUCLEON Srl

Via Via Ribes 5 - 10010 C/O Bioindustrypark del Canavese, Colleretto Giocosa,ITALY

Telephone: 0039 0125538301
Fax: 0039 0125538791
Web site: www.bionucleon.com
E-mail: info@bionucleon.com
Contact: Dr. Roberto Sapio

At a Glance
Status: SME
Founded: 2005
Employees: 3

Main Activity
Bionucleon Srl is a start-up biotech located in the Bioindustry Park (Turin) dedicated to the exploitation of nucleic acid technologies, an area of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. The company aims to: develop a new thecnology to screen new synthetic aptamers, push forward oligonucleotide analogues into our R&D pipeline; provide high quality peptide nucleic acid (PNA), conjugate and chimeric oligos, to meet our customers' needs. On May, 2006 - Bionucleon won the Unioncamere prize "Best Young Innovative Italian Enterprise".
Among the other research programmes, Bionucleon Srl is developing a process to obtain aptamers made of oligonucleotides analogues, such as pna, which are resistant to nuclease degradation. Pna aptamers would be the representative of a new class of ligands, resistant to degradation, very stable, non toxic, highly specific, and selex-independent.

Company Strengths
HIGH QUALITY PRODUCTS: Custom oligonucleotides, peptide nucleic acid and ibrid oligos with improved serum resistance for in vivo application.From ug to mg.
LICENSES/TRADE MARKS/QUALITY CERTIFICATIONS/PATENTS: 1 PCT patent on screening technology1 PCT on breast cancer mRNA sequence
INNOVATIVE PROCESSES/SERVICES/PRODUCTS: Custom oligonucleotide synthesis service
R&D CAPACITY: One Oligo synthetize, one Peptide synthetizer, two HPLC systems and Maldi and Esi systems.
EXPERTISE: Nucleic acid synthesis, antisense technology, oligo for drug discovery application.

Customer References
ASM - asm research chemical/Germany, Bioindustrypark Spa/ Italy, Creabilis therpeutics Spa /Italy

Sector
BIOTECHNOLOGY
MEDICAL BIOTECHNOLOGY
-Biopharmaceuticals
-Diagnostics
-Research and development
-Other drug discovery
FOOD BIOTECHNOLOGY
-Research and development

Type of Cooperation
TECHNICAL CO-OPERATION
- TECHNOLOGY TRANSFER OR PRODUCTION LICENSE
FINANCIAL CO-OPERATION
- DIRECT INVESTMENTS
- FINANCIAL PARTICIPATION
GENERAL CO-OPERATION
-JOINT CREATION OF AN ENTERPRISE, CONSORTIUM OR HOLDING
-DIRECT INVESTMENTS
-NEW PROJECTS DEVELOPMENT
-DEVELOPMENT OF NEW PRODUCTS
-TECHNOLOGY TRANSFER OR PRODUCTION LICENSE.


< Home


PER I VISITATORI ITALIANI www.ice.gov.it

Disclaimer - ©Copyright - Italian Institute for Foreign Trade